Seborrhea.
Falusi OO.
Pediatr Rev. 2019 Feb;40(2):93-95. doi: 10.1542/pir.2017-0215.
Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism.
Rho NK, Gil YC.
Toxins (Basel). 2021 Nov 19;13(11):817. doi: 10.3390/toxins13110817.
Diagnosis and treatment of seborrheic dermatitis.
Clark GW, Pope SM, Jaboori KA.
Am Fam Physician. 2015 Feb 1;91(3):185-90.
Unmet needs for patients with seborrheic dermatitis.
Jackson JM, Alexis A, Zirwas M, Taylor S.
J Am Acad Dermatol. 2024 Mar;90(3):597-604. doi: 10.1016/j.jaad.2022.12.017. Epub 2022 Dec 17.
Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options.
Sowell J, Pena SM, Elewski BE.
Drugs Aging. 2022 May;39(5):315-321. doi: 10.1007/s40266-022-00930-5. Epub 2022 Apr 8.
Oily skin: an overview.
Sakuma TH, Maibach HI.
Skin Pharmacol Physiol. 2012;25(5):227-35. doi: 10.1159/000338978. Epub 2012 Jun 20.
Seborrhoeic dermatitis of the scalp.
Naldi L, Diphoorn J.
BMJ Clin Evid. 2015 May 27;2015:1713.
Seborrheic dermatitis: an overview.
Schwartz RA, Janusz CA, Janniger CK.
Am Fam Physician. 2006 Jul 1;74(1):125-30.
Seborrheic dermatitis: topical therapeutics and formulation design.
Mangion SE, Mackenzie L, Roberts MS, Holmes AM.
Eur J Pharm Biopharm. 2023 Apr;185:148-164. doi: 10.1016/j.ejpb.2023.01.023. Epub 2023 Feb 25.
Sensitive Scalp: Diagnosis and Practical Management.
Guerra-Tapia A, González-Guerra E.
Actas Dermosifiliogr. 2023 Feb;114(2):141-146. doi: 10.1016/j.ad.2022.09.009. Epub 2022 Sep 26.
